1 D - Traducciones

New Immune Therapy Clears Deadly Childhood Brain Tumors In Mice

Researchers at UC San Francisco have announced a major advance against diffuse midline glioma, one of the most aggressive and historically incurable childhood brain cancers. These tumors grow in a delicate part of the brainstem, so surgery is rarely an option and families have had few answers. In preclinical studies, scientists tested a newly engineered immune-cell therapy called B-SYNC that trains a patient’s own immune cells to recognize tumor cells. The treatment completely eliminated brain tumors in every animal treated and left behind immune memory cells that stopped the cancer from returning. The approach aims to spare healthy tissue instead of relying on harsh treatments that damage it. Researchers stress that moving from laboratory success to human trials is the next critical hurdle. Human clinical trials are now planned to begin at UCSF Health as early as April 2027.

image
advertisement
"We will never ask you to login, or register through a third-party advertisement."